• Endoglin (CD105) is a structural part of the TGF-β receptor that causes the new vesselsto form and endothelial cells to proliferate. Several studies haverevealed that CD105 can emerge as a potent prognostic indicator andbiomarker for monoclonal antibody treatment in GBM patients.213,241. The gene discussed is ENG; the disease is glioblastoma.